Slide background
Slide background




EIGA | Quality Risk Management for Medicinal Gas Cylinder Filling

ID 10368 | | Visite: 5007 | Documenti Chemicals EntiPermalink: https://www.certifico.com/id/10368

EIGA Doc 228 2020

EIGA | Quality Risk Management for Medicinal Gas Cylinder Filling

Use of Quality Risk Management for Preparation of Validation Protocols for Medicinal Gas Cylinder Filling

EIGA Doc. 228/20

This publication is intended to provide guidance on preparing the protocols for performing validation of systems used for filling medicinal gas cylinders, in compliance with Good Manufacturing Practices.

It provides an overall risk assessment to identify and evaluate potential critical steps in the manufacturing processes for filling medicinal gas cylinders.

This publication provides guidance to EIGA members on how to perform the risk assessment of their medicinal gases manufacturing operations at container filling facilities.

Process validation should establish whether all quality attributes and process parameters, which are considered important for ensuring the validated state and acceptable product quality, can be consistently met by the process. The basis by which process parameters and quality attributes were identified as being critical or non-critical should be clearly documented, taking into account the results of any risk assessment activities.

Variations from the typical cylinder filling process configuration exist. Companies shall assess variations and determine if changes from this guidance are necessary.

The approach and activities in this publication are designed to ensure that these gases, which are classified as medicinal products, meet the defined product quality specifications.

The risk management process shall be used to determine the individual steps in the validation protocol(s) to ensure that the installation is:

- installed to the design drawings used for the quality risk assessment;
- set up and calibrated to define procedures;
- capable of producing finished product to the appropriate product quality specifications; and
- compliant with good manufacturing practices (GMP) criteria.

In addition, it shall demonstrate:

- each of the critical steps in the process are covered by a documented work instruction; and
- approved operators have been appropriately trained and their competency has been assessed

_______

Table of Contents
1 Introduction
2 Scope and purpose
2.1 Scope
2.2 Purpose
3 Definitions
3.1 Publication terminology
3.2 Technical definitions
4 Process description
5 Risk analysis methodology
6 Risk analysis matrix (FMEA)
7 Risk analysis results summary
8 References
9 Other references

...

Fonte: EIGA

Collegati:

Descrizione Livello Dimensione Downloads
Allegato riservato Quality Risk Management for Medicinal Gas Cylinder Filling.pdf
EIGA Doc. 228/220
461 kB 1

Tags: Chemicals EIGA Abbonati Chemicals

Articoli correlati

Ultimi archiviati Chemicals

ECHA Annual report 2024
Apr 19, 2025 566

ECHA Annual report 2024

ECHA Annual report 2024 ID 23848 | 19.04.2025 / Attached ECHA’s achievements in 2024 reflect a strong commitment to our strategic goals and priorities, as well as our vision of chemical safety through science, collaboration and knowledge. We continued to progress and implement our existing legal… Leggi tutto
Piano nazionale di controllo ufficiale degli additivi e aromi alimentari 2025 2027
Apr 17, 2025 655

Piano nazionale di controllo ufficiale degli additivi e aromi alimentari 2025-2027

Piano nazionale di controllo ufficiale degli additivi e aromi alimentari 2025-2027 ID 23839 | 17.04.2025 / In allegato Piano nazionale di controllo ufficiale degli additivi e aromi alimentari come materia prima e negli alimenti comprese le sostanze aromatizzanti di affumicatura anni 2025-2027 Il… Leggi tutto
Apr 08, 2025 763

Decreto 27 marzo 2025 | Suppl. 11.7 Farmacopea europea 11ª ed.

Decreto 27 marzo 2025 | Suppl. 11.7 Farmacopea europea 11ª ed. ID 23772 | 08.04.2025 Decreto 27 marzo 2025 Entrata in vigore dei testi, nelle lingue inglese e francese, pubblicati nel supplemento 11.7 della 11ª edizione della Farmacopea europea. (GU n.82 del 08.04.2025) _________ Art. 1. 1. I testi… Leggi tutto
Apr 07, 2025 756

Regolamento delegato (UE) 2025/687

Regolamento delegato (UE) 2025/687 ID 23761 | 07.04.2025 Regolamento delegato (UE) 2025/687 della Commissione, del 30 gennaio 2025, che modifica il regolamento delegato (UE) 2019/624 per quanto riguarda le ispezioni ante mortem presso i macelli, le ispezioni ante mortem presso l’azienda di… Leggi tutto
Mar 20, 2025 850

Regolamento delegato (UE) 2020/1413

Regolamento delegato (UE) 2020/1413 ID 23662 | 20.03.2025 Regolamento delegato (UE) 2020/1413 della Commissione del 29 giugno 2020 che rettifica la versione in lingua svedese dell’allegato I del regolamento (CE) n. 1272/2008 del Parlamento europeo e del Consiglio relativo alla classificazione,… Leggi tutto
IARC Monograph Volume 58
Mar 17, 2025 856

IARC Monographs Volume 58 / 1993

IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 58 / IARC 1993 ID 23643 | 17.03.2025 / Attached Beryllium, Cadmium, Mercury, and Exposures in the Glass Manufacturing Industry Evaluates the carcinogenic risk to humans posed by exposure to selected metals and their compounds.… Leggi tutto

Più letti Chemicals

Notifica HACCP
Apr 05, 2022 98857

Notifica ai fini registrazione Regolamento CE n. 852/2004

Notifica ai fini della registrazione (Reg. CE n. 852/2004) - Ex notifica sanitaria alimentare ID 7901 | 06.03.2019 / Modello notifica allegato [panel]Regolamento (CE) 852/2004...Articolo 6 Controlli ufficiali, registrazione e riconoscimento 1. Gli operatori del settore alimentare collaborano con le… Leggi tutto